Caidya is a contract research organization that supports biopharmaceutical companies with clinical development and regulatory services. The company employs about 350 people and recently added 39 new team members while 43 employees departed. This level of movement suggests an actively evolving workforce geared toward meeting sponsor demand across multiple therapeutic areas. The headcount data points to a midsize, globally dispersed organization that balances operational delivery with specialized scientific expertise.
Caidya’s largest staff concentration is in Healthcare-focused roles, which account for roughly one-third of all employees (115). Engineering is the second-largest group at 46 employees, underscoring the technical infrastructure required to manage clinical data and digital platforms. Business Management (43), Program & Project Management (32), and Finance & Administration (31) provide the backbone for governance, study execution, and fiscal oversight. Smaller but important teams such as Information Technology (20), Sales & Support (17), Human Resources (12), Marketing & Product (11), and an assorted “Other” category (23) round out the talent mix, illustrating a balanced spread between scientific operations and corporate functions.
Headquarters activity is distributed across several North Carolina hubs, led by Raleigh with 29 employees and supported by Durham (9), Cary (9), Charlotte (5), and Wilmington (4). Outside the state, Boston hosts 7 staff and Philadelphia 8, reflecting connections to major U.S. biotech clusters. Internationally, the United Kingdom and Taipei each have 5–7 employees, indicating early footprints for overseas trial support. A significant portion of the workforce (267) is classified under “Other,” demonstrating Caidya’s flexible, geographically diverse model that leverages remote staff and regional offices to service global studies.